TGA Approval

INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation (211601)

ARTG ID

211601

ARTG Name

INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation

Sponsor

GlaxoSmithKline Australia Pty Ltd

ARTG Date

July 8, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

GLAXOSMITHKLINE AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/a9b4684b42cc480e91da15388361c12e.pdf

https://medical-cdn.nocode.com/drug_tga/73c15579869465bb4ee707709f7d0c42.pdf

Ingredient Name

umeclidinium bromide

Empowering clinical research with data-driven insights and AI-powered tools.

INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation (211601) - TGA 批准文号 | MedPath